Metraipolis › archive › dc_98c2c40dc331

Benzoxazole Derivatives as Potent FXR and PPARα Dual Agonists With Anti-Fibrotic and Metabolic Regulatory Effects — Europe PMC PMID:41159141

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41159141
DOI: 10.1002/mco2.70442
License (as archived): solo-consultazione
Archived: 2026-11-09T01:27:32.391Z
SHA-256 of the archived text: 3a6fe835f2072fcef758979078f065b7ebec069c17208f599172d23c5a57f533
Stable URL of this page: https://metraipolis.com/documento/dc_98c2c40dc331

How to cite

Benzoxazole Derivatives as Potent FXR and PPARα Dual Agonists With Anti-Fibrotic and Metabolic Regulatory Effects — Europe PMC PMID:41159141 — Europe PMC (en), https://europepmc.org/article/MED/41159141 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_98c2c40dc331 (Metraipolis archive dc_98c2c40dc331, sha256 3a6fe835f2072fcef758979078f065b7ebec069c17208f599172d23c5a57f533)

BibTeX

@misc{dc98c2c40dc331,
  title = {Benzoxazole Derivatives as Potent FXR and PPARα Dual Agonists With Anti-Fibrotic and Metabolic Regulatory Effects — Europe PMC PMID:41159141},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41159141},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_98c2c40dc331; sha256 3a6fe835f2072fcef758979078f065b7ebec069c17208f599172d23c5a57f533},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41159141. Agents can read the archived copy with the MCP tool read_document.